Intech Investment Management LLC Sells 40,399 Shares of Cigna Group $CI

Intech Investment Management LLC reduced its stake in shares of Cigna Group (NYSE:CI) by 55.6% during the fourth quarter, Holdings Channel reports. The institutional investor owned 32,325 shares of the health services provider’s stock after selling 40,399 shares during the quarter. Intech Investment Management LLC’s holdings in Cigna Group were worth $8,897,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of Cigna Group by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after buying an additional 414,834 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after buying an additional 903,334 shares during the last quarter. Dodge & Cox grew its stake in shares of Cigna Group by 4.0% during the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after buying an additional 354,615 shares during the last quarter. Sanders Capital LLC grew its stake in shares of Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after buying an additional 35,150 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Cigna Group by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 6,051,370 shares of the health services provider’s stock valued at $1,658,055,000 after buying an additional 48,474 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Cigna Group Stock Performance

Cigna Group stock opened at $277.08 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm has a 50-day moving average of $278.32 and a 200-day moving average of $276.88. The firm has a market cap of $73.30 billion, a P/E ratio of 11.75, a P/E/G ratio of 1.02 and a beta of 0.30. Cigna Group has a 1-year low of $239.51 and a 1-year high of $338.89.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. Cigna Group’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the prior year, the business posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts expect that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 205,904 shares of company stock worth $60,277,068 over the last three months. Company insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Guggenheim raised their price objective on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Mizuho set a $330.00 price objective on Cigna Group in a research note on Friday, May 1st. Sanford C. Bernstein raised their price objective on Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a research note on Tuesday, May 5th. Cantor Fitzgerald raised their price objective on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Finally, Morgan Stanley increased their target price on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $339.50.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.